Research map: Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab–Lenvatinib: A Retrospective Real-World Study

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Trastuzumab Deruxtecan in Metastatic Urothelial Carcinoma with NGS-Detected ERBB2 Amplification: A Four-Patient Real-World Case Series · 2026 · Related
  3. Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma · Bo Hu · 2014 · 2513 citations · Cited by this paper
  4. Early Adherence to Immunomodulators in Multiple Myeloma: Retrospective Observations from a Safety-Net Hospital · 2026 · Related
  5. Endometrial cancer · Emma J Crosbie · 2022 · 1383 citations · Cited by this paper
  6. Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options · 2026 · Related
  7. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab · Stefan Diem · 2017 · 1044 citations · Cited by this paper
  8. Hyperbaric Oxygen Therapy for Late Radiation-Induced Duodenal Toxicity After Stereotactic Body Radiotherapy in a Patient with Cholangiocellular Carcinoma: A Unique Case Report · 2026 · Related
  9. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer · Mansoor Raza Mirza · 2023 · 870 citations · Cited by this paper
  10. Older Age Does Not Have an Impact on Postoperative Complication Risk Following Transurethral Resection of the Bladder Tumor · 2026 · Related
  11. The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis · Feng Li · 2021 · 379 citations · Cited by this paper
  12. ESR1 Y537S Detected in a Brain Metastasis but Not in Plasma ctDNA in HR+/HER2-Low Metastatic Breast Cancer: A Case Report · 2026 · Related
  13. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer · Yu‐Suo Tong · 2017 · 243 citations · Cited by this paper
  14. Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives · 2026 · Related
  15. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model · Qiwen Deng · 2015 · 215 citations · Cited by this paper
  16. The Efficacy of Transcutaneous Electrical Acupoint Stimulation as an Adjunct to Standard Bladder Training for Bladder Emptying After Radical Hysterectomy for Cervical Cancer: A Randomized Controlled Trial · 2026 · Related
  17. Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals · Wanying Guo · 2019 · 204 citations · Cited by this paper
  18. Response to Zona, E.E.; Israel, J.S. Toward Individualized Management: A Commentary on Perioperative Systemic Therapy Guidelines in Breast Cancer Surgery and Reconstruction. Comment on “Galuia et al. Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations. Curr. Oncol. 2025, 32, 154” · 2026 · Related
  19. Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775 · Vicky Makker · 2023 · 157 citations · Cited by this paper
  20. Using Q-Methodology to Identify Core Illness Experience Dimensions in Treated Lymphoma Patients · 2026 · Related
  21. A review on lymphocyte radiosensitivity and its impact on radiotherapy · Harald Paganetti · 2023 · 142 citations · Cited by this paper
  22. Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer · Yi Zhang · 2019 · 117 citations · Cited by this paper
  23. PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis · Hongsheng Deng · 2022 · 113 citations · Cited by this paper
  24. Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer · Yihong Huang · 2021 · 81 citations · Cited by this paper
  25. Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta‑analysis · Junyan Kou · 2023 · 81 citations · Cited by this paper
  26. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer · Jeffrey How · 2021 · 57 citations · Cited by this paper
  27. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer · Sho Matsubara · 2021 · 51 citations · Cited by this paper
  28. Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors · Murtaza Ahmed · 2021 · 45 citations · Cited by this paper
  29. Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis · Yan Wang · 2023 · 25 citations · Cited by this paper
  30. Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor · Qingqing Chen · 2024 · 22 citations · Cited by this paper
  31. Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis · Pengtian Ji · 2024 · 18 citations · Cited by this paper
  32. Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients · Boer Deng · 2024 · 10 citations · Cited by this paper
  33. Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis · Guo‐Rong Chen · 2025 · 8 citations · Cited by this paper
  34. Systemic immune-inflammation index and lymphocyte-to-monocyte ratio predict recurrence after radical surgery for stage I/II endometrial cancer · Xinxin Hu · 2025 · 4 citations · Cited by this paper
  35. Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes · Li Chen · 2022 · 3 citations · Cited by this paper
  36. Novel therapy in endometrial cancer: How much will we pay? · Angela K. Green · 2021 · 2 citations · Cited by this paper
  37. The systemic immune-inflammation index in the efficacy prediction of neoadjuvant chemotherapy in patients with endometrial cancer · Jing Lin · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)